Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia (Hijiya N et al. Blood, September 2019)

Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia
Hijiya N et al. Blood, September 2019

Link to full abstract

 

Pediatric chronic myeloid leukemia presenting in a mixed phenotypic blast crisis: A rare occurrence (Bhattacharya J et al. Turk H Haematol, August 2019)

Pediatric chronic myeloid leukemia presenting in a mixed phenotypic blast crisis: A rare occurrence
Bhattarcharya J et al. Turk H Haematol, August 2019

Link to full abstract

 

Effect of imatinib on growth in children with chronic myeloid leukemia (Boddu D et al. Pediatr Hematol Oncol, July 2019)

Effect of imatinib on growth in children with chronic myeloid leukemia
Boddu D et al. Pediatr Hematol Oncol, July 2019 (epub ahead of print)

The small problem when treating childhood chronic myeloid leukemia (Suttorp M et al. Pediatr Hematol Oncol, July 2019)

The small problem when treating childhood chronic myeloid leukemia
Suttorp M et al. Pediatr Hematol Oncol, July 2019 (epub ahead of print)

Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia (Liu Y et al. AMB Express, July 2019)

Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia
Liu Y et al. AMB Express, July 2019

  1. Large amplicon droplet PCR for DNA-based monitoring of pediatric chronic myeloid leukaemia (Krumbholz M et al. J Cell Mol Med, June 2019)
  2. Favourable of de novo advanced phases of childhood chronic myeloid leukemia (Millot F et al. Eur J Cancer, May 2019)
  3. How I treat chronic myeloid leukemia in children and adolescents (Hijiya N et al. Blood, March 2019)
  4. Discontinuation of imatinib in children with chronic myeloid leukaemia in sustained deep molecular remission: results of the STOP IMAPED study (de Bruin CMA et al. Br J Hematol, March 2019)